Carfilzomib with immunomodulatory drugs for the treatment of newly diagnosed multiple myeloma.
- DOI
- 10.1038/s41375-019-0517-6
- Published
- 2019 Sep
- Container
- Leukemia
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1038/s41375-019-0517-6,
title = {Carfilzomib with immunomodulatory drugs for the treatment of newly diagnosed multiple myeloma.},
author = {Landgren O and Sonneveld P and Jakubowiak A and Mohty M and Iskander KS and Mezzi K and Siegel DS},
year = {2019},
journal = {Leukemia},
doi = {10.1038/s41375-019-0517-6},
url = {https://doi.org/10.1038/s41375-019-0517-6}
}RIS
TY - JOUR TI - Carfilzomib with immunomodulatory drugs for the treatment of newly diagnosed multiple myeloma. AU - Landgren O AU - Sonneveld P AU - Jakubowiak A AU - Mohty M AU - Iskander KS AU - Mezzi K AU - Siegel DS PY - 2019 JO - Leukemia DO - 10.1038/s41375-019-0517-6 UR - https://doi.org/10.1038/s41375-019-0517-6 ER -
APA
O, L., P, S., A, J., M, M., KS, I., K, M., & DS, S. (2019). Carfilzomib with immunomodulatory drugs for the treatment of newly diagnosed multiple myeloma.. Leukemia. https://doi.org/10.1038/s41375-019-0517-6
Source records
- pubmed · retrieved 2026-09-25T23:49:47.734Z